Barbara Gayle Duncan - Feb 22, 2024 Form 4 Insider Report for Ovid Therapeutics Inc. (OVID)

Role
Director
Signature
/s/ Danielle Mann for Barbara Duncan by POA
Stock symbol
OVID
Transactions as of
Feb 22, 2024
Transactions value $
$0
Form type
4
Date filed
2/26/2024, 05:54 PM
Previous filing
Jun 21, 2023
Next filing
Apr 29, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OVID Stock Option (Right to Buy) Award $0 +30K $0.00 30K Feb 22, 2024 Common Stock 30K $3.68 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest in full on February 22, 2025, subject to the Reporting Person's continuous service through such vesting date.